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A B S T R A C T   
Microbial infection is a serious and challenging clinical complication that has attracted widespread interest in 
last decades. In this context, we present a strategy based on deep eutectic solvents (DES) to explore these unmet 
medical needs. DES systems based on saturated fatty acids, namely, capric acid (CA), myristic acid (MA), lauric 
acid (LA) and stearic acid (SA) were produced and fully characterized at a physicochemical level. The thermal 
characterization results indicate a depression of the melting point in DES form when compared with the starting 
compounds to near-physiological levels, whereas via polarized optic microscopy insights on the homogeneity/ 
separation of the counterparts were obtained. Regarding, physicochemical properties, temperature also has a 
great effect on the viscosity of the eutectic systems, the higher the temperature the lower the viscosity observed. 
The antimicrobial potential of DES systems was evaluated against a broad spectrum of microorganisms. The 
obtained results show that DES retain the antimicrobial of the counterparts possibly present synergistic effects 
between components, mainly in the CA:MA formulation. The systems revealed significant antimicrobial activity 
against the tested Gram-positive bacteria and C. albicans, with the CA:LA system showing the greatest overall 
inhibitory/bactericidal activity. This system was then used for a biofilm removal/detachment assay where 
relevant activity is evident against the prementioned organisms and E. coli without need of additional physical 
force. The obtained results illustrate the potential of saturated fatty acid-based DES when compared with isolated 
fatty acids as preventive/therapeutic options against microbial infections and/or components of novel ther-
moresponsive biomedical devices for antibacterial purposes.   
1. Introduction 
The development of new designer green solvents that exhibit far 
enhanced properties compared with those of organic solvents is a key 
feature in green chemistry, as it allows to circumvent the harsh condi-
tions currently employed in several chemical processes (e.g., separation 
and extraction processes) (Hayyan et al., 2015; Liu et al., 2015; Mbous 
et al., 2017; Mouden et al., 2017). Introduced by Abbot and coworkers in 
2004 (Abbott et al., 2003, 2004), deep eutectic solvents (DES) have 
emerged as a powerful alternative to the conventional organic solvents 
and also to their analogues ionic liquids (ILs) (Mouden et al., 2017; 
Alonso et al., 2016; Tang and Row, 2013; Xu et al., 2017). DES are 
commonly defined as a mixture of two or more compounds, which at 
certain molar ratio present a significant reduction on the melting point 
of the pure starting compounds (Liu et al., 2015; Mbous et al., 2017; 
Mouden et al., 2017; Smith et al., 2014; Tang et al., 2015). The 
depression on the melting point to values lower than the ones predicted 
from the known enthalpies of fusion of the individual compounds, is 
usually ascribed to the establishment of hydrogen bonding interactions 
between the compounds (Guti�errez et al., 2009, 2010). Besides 
hydrogen bonding interactions, electrostatic interactions and Van der 
Waals forces may also play an important role (Alonso et al., 2016; Tang 
and Row, 2013; Smith et al., 2014; Abbott et al., 2006; del Monte et al., 
2014; Paiva et al., 2014). 
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The variety of compounds able to form a DES are virtually unlimited 
accounting for possibly to 106 different combinations, turning these 
solvents highly versatile and flexible for several applications (Alonso 
et al., 2016; Tang and Row, 2013; Smith et al., 2014; Abbott et al., 2006; 
del Monte et al., 2014). The biological and physicochemical properties 
of DES can also be finely tuned by the nature of the chemicals used to 
form a DES, coupled with a proper selection of the molar ratio, water 
content and temperature (Paiva et al., 2014; Dai et al., 2015; Jeong 
et al., 2015). DES share some of the promising characteristics of ILs but 
contrarily to ILs, DES fully obey the green chemistry metrics (Paiva 
et al., 2014; de María and Maugeri, 2011; Pena-Pereira and Namie�snik, 
2014; Zhao and Baker, 2013). The major advantages over their analogue 
solvents are the easy preparation, lower cost of production, broader 
selection for design purposes and biodegradability (Alonso et al., 2016; 
Mainberger et al., 2017; Wagle et al., 2014; Zainal-Abidin et al., 2017). 
All these remarkable properties accelerate the pace to a strong entrance 
of DES in several fields, including the CO2 capture, biocatalysis, elec-
trochemistry, organic synthesis, cosmetics and biomedical applications 
(Alonso et al., 2016; Tang and Row, 2013; Smith et al., 2014; Abbott 
et al., 2006; del Monte et al., 2014). One of the major field of application 
for DES is the extraction of diverse bioactive compounds from various 
biomass types (e.g., phenolics compounds from plants, microalgae 
fractionation, lignocellulosic materials) due to the ability of DES to be 
used either as an extraction solvent or as a delivery medium of the 
extract (Kumar et al., 2018; Ruesgas-Ram�on et al., 2017; Sed et al., 
2018). In the biomedical field, DES have been extensively used to 
dissolve and extract biopolymers and also to preserve biological mate-
rials (e.g., DNA, G-quadruplexes, cells) (Paiva et al., 2014; Castro et al., 
2018). DES have also shown ability to improve the solubility, perme-
ation and absorption of a wide spectrum of solutes, including the active 
pharmaceutical ingredients (API’s), being hence called, therapeutic 
deep eutectic solvents (THEDES) (StottWilliams and Barry, 1998; Aroso 
et al., 2016; Duarte et al., 2017; Silva et al., 2018; Morrison et al., 2009). 
Few recent publications have also made significant contribution on the 
development of DES with antibacterial properties which suggest the 
potential of DES as a broad-spectrum antiseptic agent for therapeutic 
and also preventive applications (Rado�sevi�c et al., 2018; Wikene et al., 
2015; García-Argüelles et al., 2013; Zakrewsky et al., 2016; Zhao et al., 
2015; Hayyan et al., 2013). 
Based on that, herein, the main goal was to unveil the antimicrobial 
potential of fatty acids while in DES form due to the possible synergistic 
effects among the counterparts. The antibacterial and antifungal prop-
erties of fatty acids are well-known and synergistic effects among fatty 
acids have also been reported (Batovska et al., 2009; Kitahara et al., 
2004; Lee and Jo, 2016; Nakatsuji et al., 2009). Furthermore, fatty acid’s 
antimicrobial properties are mainly attributed to nonspecific action 
mechanisms, i.e. membrane dissolution/destabilization, which is useful 
not only due to its widespread effect on multiple microorganisms but 
also due to the lower chance of resistance dissemination/acquisition 
(Desbois and Smith, 2010; Kabara et al., 1972; Ouattara et al., 1997; 
Zheng et al., 2005). However, to the best of our knowledge up to now the 
antimicrobial properties of DES based on fatty acids were not yet re-
ported. The antimicrobial properties of fatty acids are dependent on 
several factors including chain size, hydrophobicity, number and posi-
tion double bonds and functional groups (Desbois and Smith, 2010; 
Kabara et al., 1972; Zheng et al., 2005; Campbell and Cronan, 2001; 
Galbraith and Miller, 1973). Thereby, our main interest in this study was 
to get insights on the possible therapeutic use of DES based on saturated 
fatty acids, combining capric acid (CA) 10C with other saturated fatty 
acids with different chain size length (i.e., lauric acid (LA) 12C, myristic 
acid (MA) 14C, stearic acid (SA) 18C, as reported elsewhere (Wang and 
Meng, 2010). The selected blends present a melting temperature near 
the physiological temperature and are composed by fatty acids with 
well-known antibacterial properties. Our comprehensive strategy in-
cludes the physicochemical characterization followed by a screening of 
their antimicrobial properties against a wide spectrum of 
microorganisms, according to their prevalence in most of the health 
problems and also their common use for testing of different substances 
(Fig. 1). Additionally, the potential of these DES systems to promote a 
spontaneous detachment of biofilms were also evaluated without the use 
of additional antibiotics and physical forces. 
2. Materials and methods 
2.1. DES preparation 
During the preparation of the DES, MA (ref.70082, Sigma Aldrich), 
SA (ref. 175366, Sigma Aldrich) and CA (ref. C1875, Sigma Aldrich) 
were used as raw materials. The systems were prepared according to a 
previous work reported elsewhere (Wang and Meng, 2010). Briefly, the 
systems were prepared by simply mixing the components at 70 �C, under 
constant stirring. After 30 min, a clear liquid solution was formed, and 
the mixture was slowly cooled down to room temperature (RT) until 
further use. 
2.2. Polarized optical microscopy (POM) 
Optical characterization of different formulations of DES (i.e., CA: 
LA; CA:SA; CA:MA) was carried out at RT by POM using and Olympus 
BH2 transmission microscope (Olympus, UK) coupled with a Leica 
digital camera DFC 280 (Leica, UK). The formulations were deposited on 
a microscopic glass slide and micrographs were obtained at RT. 
2.3. Thermal analysis 
Differential Scanning Calorimetry (DSC). The DSC experiments were 
performed in a TA instrument DSC Q100 model (Thermal analysis & 
analysers, USA). The temperature ramp included a heating step from 0C 
to 80 �C (heating rate 5 �C min  1), followed by an isothermal step of 2 
min prior to cooling down the system to 20 �C. 
2.4. Viscosity measurements 
The viscosity of the different DES was measured using a Kinexus Prot 
Rheometer (Kinuxus Prot, MaL 1097376, Malvern) fitted with parallel 
plate geometry with diameter of 20 mm (PU20 SR1740 SS) and gap of 1 
mm. The viscosity of the different formulations of DES was assessed 
under controlled stress conditions and with a shear rate of 10 s  1. After 
equilibrating the sample temperature at 20 �C during 5 min, a temper-
ature scan was performed from 50 �C to 15 �C at 2 �C min  1. 
2.5. Disk diffusion assay 
The antimicrobial activity of DES was determined using Staphylo-
coccus aureus ATCC 25923, S. aureus ATCC 700698 (Methicillin-resistant 
strain, MRSA), S. epidermis ATCC 35984 (Methicillin-resistant strain, 
MRSE), Pseudomonas aeruginosa ATCC 27853, Escherichia coli ATCC 
25922 and Candida albicans ATCC 90029, according to the guidelines of 
Clinical and Laboratory Standards Institute (CLSI). Initially, the anti-
microbial activity was screened out using the disc diffusion approach, 
adapting a methodology elsewhere described by Ferreira et al. 
(AbbottBoothby et al., 2004). Gentamicin sulphate (ref. G1914, Sigma 
Aldrich) at 50 mg/mL, Fluconazole (ref. Y0000557, Sigma Aldrich) at 5 
mg/mL and sterile water were used as positive and negative controls, 
respectively. Additionally, the effect of each fatty acid was also evalu-
ated. The discs (CT0998B, Oxford) were prepared by incubating them in 
DES formulations and controls, as elsewhere reported (Silva et al., 
2019). The disks impregnated with the different formulations were 
placed on the inoculated agar. The plates were incubated during 24 h at 
37 �C (bacterial strains) and 30 �C (C. albicans). After incubation, the 
diameter of the clear zone (inhibition halo diameter) was determined to 
assess the antimicrobial properties of each formulation. 
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2.6. Assessment of minimal inhibitory concentrations (MICs), minimal 
fungicidal concentration (MFCs) and minimal bactericidal concentration 
(MBCs) 
MICs/MFCs/MBCs were determined by microbroth dilution tech-
nique. Briefly, standard solutions of fatty acids in powder and DES form 
were prepared under sterile conditions by first dissolving the weighted 
compounds in DMSO (ref. 276855, Sigma), followed by serial dilution in 
Müller-Hinton Broth medium (MHB, ref 70192-500 g, Sigma Aldrich) 
maintaining a final 10%(v/v) percentage of DMSO. During the dilution 
process, the microtubes were warmed up to 70 �C and homogenized 
using an ultrasonic bath. Afterwards, the microtubes containing the 
different formulations (500 μL/tube) were inoculated with 500 μL of 
bacterial suspension at 1–2x106 CFUs/mL in MHB. As control, MHB (i.e., 
bacteria-free), MHB (with no added compounds), a solution of 10% (v/ 
v) DMSO in MHB and the pure components were used. The microtubes 
were incubated at 37 �C (bacterial strains) or 30 �C (C. albicans) under 
shaking for 24 h and the bacterial growth was monitored. The MICs/ 
MFCs of each compound were considered as the concentrations at which 
the tested formulations prevent the formation of turbidity in the 
microtube. However, to confirm such results and to avoid under-
estimated values (i.e., the compounds itself may cause turbidity), sub-
cultures of each concentration, were performed onto trypticase soy agar 
(TSA, Ref. 610052, Frilabo) for 24 h. This assay allows to confirm the 
MIC/MFC values, as well as, the determination of the MBC of each 
compound. The MBC were considered as the minimal concentration of 
each formulation required to lead to complete bacterial death. 
2.7. Assessment of biofilm removal efficiency 
S. aureus ATCC 700698, C. albicans ATCC 90029 and E. coli ATCC 
25922 were spread into TSA plates and left growing for 24 h at optimal 
temperature for each organism, 37 �C and 30 �C for bacteria and yeast, 
respectively. Posteriorly, suspension cultures were prepared by inocu-
lation of single colonies into TSB and grown for additional 24 h. Cultures 
were then harvested, resuspended in TSB and adjusted to approximately 
1–2x104 CFUs/mL. Subsequently, 200 μL of the previously prepared 
dilution was transferred into wells, in a 96-well polystyrene flat-bottom 
plate and incubated during 20 h at optimal temperature, for biofilm 
formation. Following biofilm formation, microbial suspensions were 
carefully removed, and sample solutions of CA:LA were added at 
different concentrations (625, 1250 and 2500 μg/mL) in ddH2O with 
10%(v/v) DMSO. After different exposure times (5, 10, 20 and 30 min) 
sample solutions were removed and 200 μL of MHB media containing 
10%(v/v) alamar blue dye (ref. BUF012B, Bio-Rad) added into the wells, 
followed by plate incubation for 1 h, at either 37 �C or 30 �C. Absorbance 
at 570 and 600 nm was then measured using a microplate reader 
(SYNERGY HT™) to calculate the removal efficiency of biofilms. SEM 
images were also obtained using a JEOL JSM-6010 LV (JEOL, Japan). 
Biofilms were established in cover slips (ref. 83.1840.002, Sarstedt) for 
20 h and treated with CA:LA (at 1250 μg/mL) for the above-mentioned 
time points. Posteriorly, sample solutions were gently removed, and 
microorganisms fixed using a phosphate-saline buffer with 10% (v/v) 
formalin for 1 h and washed with deionized water. Fixed biofilm was 
then dehydrated using by immersion in solutions with increasing con-
centrations of alcohol (20%, 50%, 70%, 90% and 100%). Finally, sam-
ples were left dry in a safety cabinet overnight and then gold-sputtered 
for SEM image acquisition. 
3. Results and discussion 
3.1. DES preparation and characterization 
In this work, DES based on saturated fatty acids were prepared as 
elsewhere reported by Meng and coworkers (Wang and Meng, 2010) and 
the formation of a liquid at RT was assessed (Table 1). DES based on CA 
and LA are liquid at RT (i.e., no insoluble particles are detected), 
whereas the other formulations are pasty-like solid at RT. The formation 
of a liquid is a strong indication of loss of lattice arrangement. 
These results were further confirmed by POM, which is a common 
tool used to assess the existence of crystal-like structures in the eutectic 
mixture even if the crystals are mixed with a liquid phase (Aroso et al., 
2016). The POM micrographs at RT corroborated the visual observation 
as in CA:LA no crystal-like formations are distinguished. Thereby, this 
formulation presents a micrograph with a full black background that is 
Fig. 1. Schematic illustration of the production steps of DES and their physicochemical and antimicrobial assessment.  
Table 1 
Summary of the different DES prepared in this study with their respective visual 





POM at room temperature 
CA:SA 4:1 White solid at RT 
CA: 
MA 
3:1 White solid at RT 
CA:LA 
2:1 Transparent liquid at 
RT 
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an indicative of a homogeneous liquid phase at RT. 
The POM assessment was combined with DSC analysis to get insights 
on the thermal events of these eutectic mixtures. According to DES 
definition, the melting point of the eutectic mixture should be far below 
than that of each counterpart due to the establishment of intermolecular 
hydrogen bonds and occasionally Van der Waals interactions (Guti�errez 
et al., 2009, 2010). In order to evaluate this, the thermograms of the 
powder and DES were performed (Fig. 2) and the results corroborated 
previous data on the literature (Wang and Meng, 2010; Yuan et al., 
2014). The thermograms of each fatty acid present a well-defined and 
unique sharp endothermic peak at � 32.3 �C, �46.6 �C, � 58.6 �C, � 73 
�C, for CA, LA, MA, SA, respectively. Additionally, the melting peak of 
CA:LA, CA:MA and CA:SA is � 22.7 �C, �24.6 �C, � 28.8 �C, respec-
tively. The peaks obtained in DES systems are different from those of the 
parent species and a clear depression in the melting point occurs which 
further suggests the supramolecular rearrangement while the com-
pounds are in DES form. Usually the depression on the melting point is 
dependent on the nature of the counterparts, molar ratio, lattice energy 
of DES and also entropy changes arising from the formation of DES 
(Smith et al., 2014; Abbott et al., 2006; Mainberger et al., 2017; Khan-
delwal et al., 2016). In all the DES a depression of the melting point 
occurs and it lowers up to near-physiological levels when compared with 
the starting compounds, which turns meaningful to explore the prop-
erties of these eutectic systems in different fields, namely in biomedical 
field. 
The viscosity of the systems was also evaluated as a function of 
temperature for the different formulations of DES (Fig. 3), as it is a 
parameter that restricts the possible pharmaceutical application of DES 
since it influences the diffusion of a liquid out of a solid support. The 
results obtained indicate that the viscosity is inversely related with 
temperature, i.e., the viscosity decreases as the temperature increases. 
Similar results have been reported for other formulations of DES, being 
known as Arrhenius-like behavior (Aroso et al., 2016, 2017; Craveiro 
et al., 2016). The DES with higher viscosity is CA:SA, followed by CA:MA 
and lastly, CA:LA. This data also suggests that the viscosity is dependent 
on the chain size of the saturated fatty acids, corroborating the DSC data 
(Fig. 2) (Dai et al., 2015; Rado�sevi�c et al., 2016; Florindo et al., 2018; 
Hayyan et al., 2012; Stefanovic et al., 2017). Beyond the effect of chain 
length size, it should be pointed out that the viscosity is also related with 
a vast hydrogen bonding network that is stablished between the coun-
terparts of DES (Zainal-Abidin et al., 2017). 
3.2. Antimicrobial assessment 
To evaluate the antimicrobial potential of the various DES formula-
tions, firstly a disk diffusion assay was carried out using the selected 
microbial strains. Inhibition halo measurements are presented in 
Table 2. The representative images of the obtained plates can be found 
as supplementary information (Tables S1–S6). 
As can be easily observed by analyzing Table 2, the DES formulations 
only show antibacterial activity against the tested Gram-positive bac-
teria (resistant and non-resistant) and C. albicans, displaying no activity 
against the P. aeruginosa and E. coli (i.e., inhibition halo � 0 mm) strains 
used. These results are in accordance with other accounts in the litera-
ture, as Gram-negative bacteria are usually resistant to the antibacterial 
activity of fatty acids due to a more complex membrane structure, with 
several studies reporting that the presence of lipopolysaccharides on the 
cell wall prevents the fatty acids from reaching cell membrane and 
exerting its effect (Kitahara et al., 2004; Desbois and Smith, 2010; 
Ouattara et al., 1997; McGaw et al., 2002). On the other hand, the cell 
wall of Gram-positive bacteria readily absorbs fatty acids allowing their 
passage into the inner membrane (Kitahara et al., 2004; Ouattara et al., 
1997). C. albicans is reported as being able to modulate its membrane 
surface hydrophobicity during growth and morphogenesis, which may 
explain its susceptibility to these compounds as it displays a hydro-
phobic membrane surface during certain stages of its life cycle to pro-
mote, among other things, virulence by enhanced adhesion to cells (Glee 
et al., 1995; Hobden et al., 1995). Furthermore, it should be noted that 
the overall lower susceptibility observed in C. albicans is possibly due to 
the lower incubation temperature for this microorganism (30 �C) when 
compared with that used for the bacteria strains (37 �C), which affect the 
diffusion of the compounds/DES formulations through the solid media, 
together with the lower viscosity at a higher temperature (Fig. 3). 
In fact, both LA and CA have documented inhibitory activity against 
C. albicans fact that for LA is not reflected in these results (Huang et al., 
2011). Likewise, MA’s lower activity and SA’s complete inactivity may 
result from their inability to diffuse through the media as these fatty 
acids have substantially higher melting points than both LA and CA 
(Fig. 2).It should be noted that for all DES formulations present an in-
hibition halo for C.albicans (i.e., inhibition halo � 12.7–15 mm), which 
further suggest the higher diffusion of DES formulations at lower tem-
perature when compared with the individual counterpart. Taking into 
account the results of this initial screening, S. aureus, MRSA, MRSE and 
C. albicans were selected for MIC/MBC/MFC assessment and the deter-
mined concentration values are presented in Table 3. Firstly, it should be 
noted that the determination of antibacterial activity of fatty acids, in 
suspension culture, is not straightforward due to the turbidity of lipidic 
solutions and their overall lack of solubility in water, as elsewhere re-
ported (Khuwijitjaru et al., 2002; Oliveira et al., 2009). To solve this 
issue, DMSO was added to the medium in such a percentage that did not 
show any effect on MICs and MBCs determination. It should be noted 
that the dilutions performed did not weaken and/or disrupt the vast 
network of intermolecular interactions, as reported elsewhere for other 
DES formulations in this concentration range (Hayyan et al., 2015, 
2016; Silva et al., 2019; Juneidi et al., 2015; Rado�sevi�c et al., 2015). The 
main advantage of DES concerns in the formation of a supramolecular 
Fig. 2. DSC thermograms obtained for powders (A) and DES (B). Peaks arising above the baseline represent endothermic peaks.  
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arrangement established due to intermolecular interactions such as 
hydrogen bonding interactions and van der waals. Thereby, when using 
a physical mixture of compounds different behaviors are obtained as in 
that situation a simple dissolution of each compound in a certain me-
dium occurred without any supramolecular arrangement, as previously 
reported (Silva et al., 2019; Pereira et al., 2019). 
The MIC/MBC/MFC results confirm the hypothesis that the inhibi-
tion halos were most likely influenced by the diffusion ability of the 
compounds and incubation temperature. This is particularly true for 
C. albicans, where both LA and MA that displayed no activity during the 
disk diffusion assay, possess MIC/MBC/MFC concentration values equal 
to those observed in the bacterial strains tested. As such, it can be stated 
that a negative result in the disk diffusion assay does not, by itself, 
suffice as an exclusion criterion for further downstream analysis in this 
particular context. Regarding the MIC/MBC/MFC values obtained for 
the DES formulations and individual counterparts, results are as ex-
pected with LA, CA and their correspondent eutectic blend CA:LA dis-
playing the highest overall antimicrobial activity, followed closely by 
CA:MA who displayed only lesser inhibitory activity regarding 
C. albicans (i.e., �1250–2500 μg/mL), and finally CA:SA with the worst 
overall performance. The antimicrobial capabilities of individual LA and 
CA are well-reported in the literature with LA being the medium chain 
aliphatic fatty acid with the greatest overall antimicrobial activity, fol-
lowed by CA. In fact, several authors have reported that, in general, 
medium and long-chain fatty acids tend to display a higher antibacterial 
effect towards gram-positive bacteria. Even when considering overall 
activity, the major consensus is that unsaturated fatty acids with 10 and 
12 carbon chain length display the highest antimicrobial potential, 
which probably means that these fatty acids present the ideal hydro-
phobic balance for appreciable bioavailability and microbial mem-
brane/wall permeation (Batovska et al., 2009; Kitahara et al., 2004; 
Nakatsuji et al., 2009; Huang et al., 2014). The less positive results 
observed for MA are most likely due to the slightly higher carbon chain 
(14C) in comparison with both CA (10C) and LA (12C), which greatly 
increases its hydrophobicity reducing its solubility and therefore 
bioavailability (Desbois and Smith, 2010; Ouattara et al., 1997; McGaw 
et al., 2002; Churchward et al., 2018; Yoon et al., 2018). In fact, SA 
dissolution was not achieved most likely due to its high carbon chain 
Fig. 3. Variation of the viscosity of the different formulations of DES as a function of the temperature.  
Table 2 
Inhibition halo measurements (diameter (mm) � SD) for the various DES formulations and individual counterparts. Results are presented by formulation/compound 
for each microbial strain tested. NI – no inhibition, NT – Not tested.  
DES/Compound E. coli P. aeruginosa S. aureus MRSA MRSE C. Albicans 
CA NI NI 15.00 � 0.00 13.33 � 0.47 20.33 � 0.94 17.33 � 0.47 
LA NI NI 15.67 � 1.53 13.33 � 0.47 14.67 � 0.47 NI 
MA NI NI 11.33 � 0.58 11.67 � 0.47 11.67 � 0.47 NI 
SA NI NI NI NI NI NI 
CA:LA NI NI 15.67 � 0.58 16.50 � 0.41 20.00 � 0.82 13.5 � 0.41 
CA:MA NI NI 14.00 � 1.00 14.33 � 0.47 15.67 � 0.47 12.7 � 0.47 
CA:SA NI NI 14.67 � 0.58 15.67 � 0.47 15.00 � 0.82 15.0 � 0.50 
Gentamicin 29.17 � 0.85 35.17 � 0.62 36.33 � 0.58 19.00 � 0.00 27.83 � 0.62 NT 
Fluconazole NT NT NT NT NT 32.67 � 0.47 
Sterile water 0.00 � 0.00 0.00 � 0.00 0.00 � 0.00 0.00 � 0.00 0.00 � 0.00 0.00 � 0.00  
Table 3 
MIC/MBC/MFC values of individual counterparts and DES. Results are presented by formulation for each microbial strain tested. ND- Not dissolved.  
DES/Raw materials MIC (μg/mL) MBC/MFC (μg/mL) 
Bacterial strain Yeast strain Bacterial strain Yeast strain 
S. aureus MRSA MRSE C. albicans S. aureus MRSA MRSE C. albicans 
CA 625 625 625 625 1250 1250 1250 1250 
LA 312.5 312.5 312.5 312.5 625 625 625 625 
MA 625 1250 1250 1250 1250 2500 2500 2500 
SA ND ND ND ND ND ND ND ND 
CA:LA 625 625 625 625 1250 1250 1250 1250 
CA:MA 625 625 625 1250 1250 1250 1250 2500 
CA:SA 1250 1250 1250 1250 2500 2500 2500 2500  
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length (18C) (Kabara et al., 1972). However, it should be noted that 
inclusion of MA in DES form appears to somewhat potentiate its disso-
lution, since CA:MA displays the same MIC/MBC/MFC values as CA, 
even though isolated MA is less potent. On the contrary, CA:SA shows 
lower inhibitory activity than isolated CA, as the established interactions 
in DES form in conjunction with the highly insoluble SA most likely 
leads to co-precipitation of both fatty acids. Thus, the data further 
suggest the supramolecular arrangement between both counterparts 
while in DES form. It is well-stablished in the literature that the supra-
molecular arrangements of DES may led to synergistic or additive ef-
fects, which in some cases led to more or less toxic systems in 
comparison with their individual counterpart (Hayyan et al., 2015, 
2016; Rado�sevi�c et al., 2015, 2018; Juneidi et al., 2015). Regarding DES 
efficacy for each of the tested microbial strains, the results are also as 
expected, with lower values for S. aureus when compared with the MRSA 
and MRSE strains which are, by nature, more competitive and resilient 
organisms (Bes et al., 2018; Igbinosa et al., 2016). Furthermore, the 
MIC/MFC values determined for C. albicans are similar to the ones ob-
tained for both MRSA and MRSE, illustrating the potential of these DES 
based on saturated fatty acid as an effective treatment and preventive 
measure for not only bacterial, but also yeast-related infections (Huang 
et al., 2011; Bergsson et al., 2001). CA:LA, the most promising formu-
lation, showed MIC/MBC/MFC concentration values of 625 μg/mL 
(395.21 μg of CA þ 229.21 μg of LA) and 1250 μg/mL (790.42 μg of CA 
þ 459.58 μg of LA), respectively which are in accordance with the 
determined values for the isolated components and existing literature 
(Kitahara et al., 2004; Kabara et al., 1972). The absolute mass compo-
sition of the various DES formulations is presented in Fig. 4. This 
widespread antimicrobial potential observed is derived, most likely, 
from the non-specific antimicrobial action mechanism of fatty acids, as 
these primarily actuate on the membrane leading to its destabiliza-
tion/dissolution causing a wide range of direct and indirect inhibitory 
effects (Desbois and Smith, 2010; Yoon et al., 2018). Thereby, using DES 
based on saturated fatty acids no drug resistance is induced due to the 
non-specific mechanism of action. Nonetheless, depending on the 
counterpart used in combination with CA, the results are different, being 
the overall antimicrobial activity increased with saturated fatty acids 
with lower chain size length. 
3.3. Biofilm removal-efficiency 
CA:LA formulation was selected for additional antimicrobial studies, 
particularly for the evaluation of biofilm permeation and dissolution 
capability. The results obtained via the alamar blue assay after biofilm 
exposure to CA:LA for different time frames are presented in Fig. 5. 
The results indicate that for all tested organisms CA:LA was effective 
in dispersing or disrupting established biofilm. Moreover, it appears that 
even the lowest concentration (625 μg/mL) applied over time can exert 
an effect comparable to the two higher concentrations used (2500 and 
1250 μg/mL) with removal rates over 50% being achieved, for most 
cases, in 10 min. These results are comparable with previous studies 
performed using DES based on betaine and erythrol for the detachment 
of Streptococcus mutants biofilm (Lim et al., 2017). To the best of our 
knowledge, this recently published study by Lee et al., in 2017 is the 
only reported instance of the use of DES for microbial biofilm disruption. 
A noteworthy point is that even though these systems showed no bac-
tericidal/inhibitory activity against the tested gram-negative strains, it 
appears that CA:LA possesses the ability to effectively disrupt the biofilm 
of the E. coli strain used in this assay. This is probably due to the system 
direct impact on the biofilm matrix which is majorly composed of hy-
drated extracellular polymeric substance that depending on the bacte-
rial species may vary from cellulose to alginate (Archer et al., 2011; 
Chandra et al., 2001; Serra et al., 2013). Furthermore, it should be 
highlighted that the results obtained show that CA:LA can successfully 
disrupt biofilm without the need of additional physical force or antibi-
otics (Archer et al., 2011; Chandra et al., 2001; Høiby et al., 2010). 
Based on the obtained results, an action mechanism of DES in estab-
lished biofilms where, upon exposure to CA:LA at tested concentrations 
there is simultaneously both biofilm detachment, due to destabilization 
of the polymeric matrix, and also a bactericidal effect due to the com-
pounds bactericidal effect on 2 of the 3 tested microorganisms at the 
applied concentrations is proposed. This dual action mechanism ex-
plains why, even though saturated fatty acid-based DES displayed no 
significant antibacterial activity against E. coli, an effect on this 
gram-negative bacteria’s biofilm was observed. To further validate the 
proposed model and the obtained results in the metabolism-based ala-
mar blue assay, samples of cultivated biofilm exposed to 1250 μg/mL for 
the different established time periods were prepared for SEM micro-
scopy (Fig. 6). 
The obtained results support the above proposed model as one can 
observe a progressive dispersion of the biofilm over time in all micro-
organisms subjected to DES exposure. Furthermore, the biofilm disper-
sion does not appear to directly correlate with the biofilm reduction 
percentage observed in the alamar blue assay, which directly supports 
the theory that a dual-action mechanism of both biofilm dispersion and 
bactericidal effects are observed (Fig. 7). 
This is most likely due to a perturbation of the biofilm’s polymer 
matrix leading both to detachment and enhanced permeation of CA:LA. 
Moreover, considering the observed results from both the alamar blue 
assay and SEM imaging, it is reliable to state that the effect which is 
primarily enhanced over time is the removal/dispersion of biofilm, as a 
gradual reduction of microbial cells is observed in all cases. Overall, 
these results are very appealing since both a gradual dispersion of bio-
film as well as bactericidal effects are achieved. 
4. Conclusions 
Inspired by the well-known antimicrobial properties of fatty acids 
and by an unmet medical challenge, our comprehensive strategy resul-
ted in the production of DES based on saturated fatty acids taking 
advantage of possible synergistic effects among the counterparts and 
also from the depression on the melting point of the DES when compared 
with the one of individual starting compounds. The antimicrobial ac-
tivity of the different formulations was evaluated against a wide panel of 
microorganisms. The most promising system was the CA:LA formulation 
with relevant antimicrobial activity towards the gram-positive bacterial 
strains used and C. albicans. Furthermore, the results obtained show that 
this system can promote biofilm detachment/removal in all microor-
ganisms tested, even for gram-negative bacteria, although most likely 
Fig. 4. Absolute mass composition of DES based on CA and other saturated 
fatty acids. 
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via different mechanisms. This study provides insight on the potential of 
DES based on saturated fatty acids as a possible broad-spectrum anti-
microbial agent that if properly harnessed can be translated into clinical 
practice as an effective preventive and/or therapeutic option against 
microbial infections in various settings. Taking advantage of the 
observed thermo-responsiveness at near physiological temperature, 
these systems are strong candidates as components to produce novel 
thermosensitive biomaterials with enhanced properties. Furthermore, 
saturated fatty acid-based DES also show promise as potential alterna-
tives to classical antibiotics, such as gentamicin, whose specific mech-
anism of action somewhat facilitates the dissemination of antibiotic 
resistance, in an age where the emergence of multi-resistant pathogens is 
a matter of great concern in the Public health agenda. 
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Fig. 6. SEM imaging of biofilm from three distinct microorganisms seeded onto cover slips with different exposure times to CA:LA eutectic blend. Results are 
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